We have recently received new NHS guidance on who is eligible to receive weight loss injections (Mounjaro/Tirzepatide).
Please read this and if you believe you are eligible then send a triage form online or contact reception.
Eligible patients must meet the following criteria:
- BMI of 35kg/m2 or more
- AND at least 4 of the following 5 qualifying co-morbidities:
- Heart disease (angina, heart attack, peripheral vascular disease, stroke)
- High blood pressure requiring treatment
- Abnormal cholesterol levels
- Obstructive sleep apnoea (sleep clinic confirmed) meeting criteria for continuous positive airways pressure.
- Type 2 diabetes mellitus.
Weight management pharmacotherapy (GLP-1s and GLP-1/GIPs) should not be prescribed for obesity by General Practice for any patient who does not meet the above criteria.
All patients prescribed weight management pharmacotherapy by General Practice must be referred to a 9 month behavioural support programme. Where a patient declines to participate in this or does not complete this programme, Mounjaro will be discontinued.